Gary Owens headshot
GO

Gary K. Owens

Professor
Unit: School of Medicine
Department: Department of Molecular Phys and Biological Physics
Office location and address
415 Lane Rd
Charlottesville, Virginia 22903
Education
BS, Pennsylvania State University
MS, Pennsylvania State University
PhD, Pennsylvania State University
Postdoc, University of Washington, Seattle
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
Source: U.S. NIH Heart, Lung, And Blood Institute
July 01, 2021 – June 30, 2025
Defining the Roles of Smooth Muscle Cells and Other Extracellular Matrix Producing Cells in Late Stage Atherosclerotic Plaque Pathogenesis
Source: Leducq Foundation for Cardiovascular Research
January 01, 2019 – December 31, 2023
Short-Term Training to Increase Diversity in Health-Related Research
Source: U.S. NIH Heart, Lung, And Blood Institute
April 25, 2018 – March 31, 2023
IL1beta signaling in SMC promotes beneficial changes in late stage atherosclerotic lesion pathogenesis
Source: U.S. NIH Heart, Lung, And Blood Institute
February 01, 2019 – January 31, 2023
MD-CVRC Basic Cardiovascular Research Training Grant Year 41-45
Source: U.S. NIH Heart, Lung, And Blood Institute
July 01, 2017 – June 30, 2022
MD-CVRC PDGFbeta Receptor Activation Promotes Atheroprotective Changes in SMC Phenotype
Source: U.S. NIH Heart, Lung, And Blood Institute
April 01, 2017 – March 31, 2022
Targeting glutamine metabolism to augment atherosclerotic plaque stability - Predoctoral Fellowship on Behalf of Anita Salamon
Source: American Heart Association
April 01, 2021 – March 31, 2022
Defining SMC Phenotypes Critical in Late Stage Atherosclerosis Pathogenesis
Source: U.S. NIH Heart, Lung, And Blood Institute
January 01, 2018 – December 31, 2021
MD-INMD AZ Master Agreement
Source: AstraZeneca
December 08, 2009 – December 31, 2021
MD-INMD CVRC Master Research Collaboration Agreement
Source: AstraZeneca
October 01, 2016 – December 31, 2021
IL1b Promotes Atheroprotective Changes in Late Stage Atherosclerotic Lesions
Source: U.S. NIH Heart, Lung, And Blood Institute
September 30, 2017 – September 29, 2021
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
Source: U.S. NIH Heart, Lung, And Blood Institute
August 01, 2017 – April 30, 2021
Perivascular smooth muscle derived macrophage-like cells maintain vessel integrity and respond to vascular remodeling
Source: American Heart Association
January 01, 2019 – December 31, 2020
Oct4 dependent expression of the adiponectin receptor T-cadherin promotes SMC investment into atherosclerotic lesions
Source: American Heart Association
January 01, 2019 – September 01, 2019
MD-INMD-CV Epigenetic Control of Vascular Smooth Muscle Cell Lineage Memory
Source: American Heart Association
July 01, 2015 – June 30, 2019
Interleukin-1 beta promotes atheroprotective changes in late stage atherosclerotic lesions
Source: American Heart Association
July 01, 2017 – June 30, 2019
Smooth muscle cell MCP1 signaling enhances atherogenesis and lesion instability
Source: American Heart Association
July 01, 2017 – June 30, 2019
Somatic Mutation-driven Clonal Hematopoiesis in Atherosclerosis ¿ International Consortium
Source: Fundación Centro Nacional de Investigaciones Cardi
September 01, 2018 – November 30, 2018
MD-CVRC Basic Cardiovascular Research Training Grant
Source: U.S. NIH Heart, Lung, And Blood Institute
July 01, 2015 – June 29, 2018
MD-DMED Short-term training to increase diversity in health-related research
Source: U.S. NIH Heart, Lung, And Blood Institute
August 24, 2012 – November 30, 2017
MD-CVRC Role of IL1b in Regulating SMC and Macrophage Differentiation in Atherosclerosis
Source: U.S. NIH Heart, Lung, And Blood Institute
December 13, 2013 – November 30, 2017
MD- CVRC-KLF4dependent maintenance of microvascular integrity
Source: American Heart Association
July 01, 2015 – June 30, 2017
MD-CVRC Role of Perivascular Cell-Derived Oct4 in Vascular Remodeling Following Hindlimb Ischemia
Source: American Heart Association
July 01, 2015 – June 30, 2017
MD-CVRC Role of OxPLs and Oct4 in SMC Phenotypic Switching in Atherosclerosis
Source: U.S. NIH Heart, Lung, And Blood Institute
June 01, 2013 – May 31, 2017
MD-CVRC Epigenetic Contol of SMC Transitions to a Multi-Potential Stem Cell-Like State
Source: U.S. NIH Heart, Lung, And Blood Institute
June 01, 2013 – March 31, 2017
Basic Cardiovascular Research Training Grant
Source: U.S. NIH Heart, Lung, And Blood Institute
July 01, 2012 – November 30, 2016
MD-CVRC-2015 VASCULATA CONFERENCE
Source: U.S. NIH Heart, Lung, And Blood Institute
August 01, 2015 – July 31, 2016
MD-CVRC Role of Col15a1 in Smooth Muscle Cell Phenotypic Modulation and Atherosclerosis
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2014 – June 30, 2016
MD-CVRC Role of Oct4 in Transition of Perivascular Cells into Cardiomyolcyte Permissive Cells Post-Myocardial Infarction
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2014 – June 30, 2016
MD-CVRC Role of OxPLs and Oct4 in SMC Phenotypic Switching in Atherosclerosis
Source: U.S. NIH Heart, Lung, And Blood Institute
June 01, 2013 – May 31, 2016
MD-CVRC Epigenetic Control of SMC Transitions to a Multi-Potential Stem Cell-Like State
Source: U.S. NIH Heart, Lung, And Blood Institute
June 01, 2013 – March 31, 2016
MD-CVRC-Vasculata 2015
Source: Gilead Sciences, Inc.
June 01, 2015 – December 31, 2015
MD-CVRC Vasculata 2015 Bristol-Myers Squibb
Source: Bristol-Myers Squibb Company
July 09, 2015 – December 31, 2015
Short-Term Training to Increase Diversity in Health-Related Research
Source: U.S. NIH Heart, Lung, And Blood Institute
August 24, 2012 – November 30, 2015
MD-CVRC Vasculata 2015
Source: AstraZeneca
June 01, 2015 – August 07, 2015
MD-CVRC The Role of SMC reversible phenotypic switching and H3K4me2 in vascular injury and repair
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2013 – June 30, 2015
Medical Scientist Training Program YR32
Source: U.S. NIH Institute of General Medical Science
July 01, 2010 – June 30, 2015
MD-CVRC Mechanisms of Activation of the IPS cell factor KLF4 by proatherogenic oxidized phospholipids in vascular smooth muscle cells
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2013 – June 30, 2014
Development of Novel Treatments for Abdominal Aorta Aneurysm Patients
Source: AstraZeneca
July 01, 2011 – March 14, 2014
MD-CVRC Role of IL1b in Regulating SMC and Macrophage Differentiaion in Atherosclerosis
Source: U.S. NIH Heart, Lung, And Blood Institute
December 13, 2013 – January 09, 2014
KLF4-Dependent Regulation of SMC Differentiation and Phenotypic Switching
Source: U.S. NIH Heart, Lung, And Blood Institute
January 12, 2010 – November 30, 2013
Postdoctoral Fellowship on Behalf of A.T. Nguyen
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2012 – September 30, 2013
Predoctoral Fellowship on Behalf of L.S. Shankman
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2011 – June 30, 2013
Predoctoral Fellowship on Behalf of M. Murgai
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2011 – June 30, 2013
Postdoctoral Fellowship on Behalf of D. Gomez
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2011 – June 30, 2013
MD-CVRC Basic Cardiovascular Research Training Grant
Source: U.S. NIH Heart, Lung, And Blood Institute
July 01, 2008 – June 29, 2013
Role of Oxidized Phospholipids in Phenotypic Switching of Smooth Muscle Cells (SM
Source: U.S. NIH Heart, Lung, And Blood Institute
February 01, 2008 – May 31, 2013
MD-CVRC Epigenetic Control of Smooth Muscle Cell Lineage and Phenotypic Switching
Source: U.S. NIH Heart, Lung, And Blood Institute
April 01, 2008 – May 31, 2013
MD-CVRC The Robert M. Berne Cardiovascular Research Center 20th Anniversary Symposium
Source: AstraZeneca
September 01, 2012 – March 31, 2013
BIOL 4930: Distinguished Major Thesis Research
Credits: 2
This course is the final semester of Independent Research for participants of the Biology Distinguished Majors Program. During this semester, students will complete their laboratory investigations, ultimately presenting the sum of their work in a written thesis. Prerequisite: Instructor Permission
BIMS 8091: CVRC Seminars
Credits: 1
CVRC Seminars
BIMS 8995: Topical Research: Research in Biomedical Sciences
Credits: 1–12
This course introduces students to biomedical research. Students conduct one or more research projects of limited scope under the direction of faculty and lab members. It is open only to graduate students in Biomedical Sciences (BIMS).
BIMS 8998: Non-Topical Research: Research in Biomedical Sciences
Credits: 1–12
This course introduces students to biomedical research. Students conduct one or more research projects of limited scope under the direction of faculty and lab members. It is open only to graduate students in Biomedical Sciences (BIMS).
BIOC 9995: Topical Research: Biochemistry and Molecular Genetics
Credits: 3–12
Topical Research
PHY 9995: Research
Credits: 3–12
Directed research on an approved problem in physiology.
PATH 9995: Topical Research
Credits: 1–12
Original research on approved problems.
BIOC 9998: Non-Topical Research: Preparation for Doctoral Research
Credits: 1–12
Non-Topical Research: Preparation for Doctoral Research
PHY 9998: Non-Topical Research, Preparation for Doctoral Research
Credits: 1–12
For doctoral research, taken before a dissertation director has been selected.
PHY 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation.
BIOC 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation, taken under the supervision of a dissertation director.
PATH 9999: Non-Topical Research
Credits: 1–12
Dissertation research credit for students who have completed their advancement to candidacy.